细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体

Recombinant Antibody to Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4)

CD152; CELIAC3; CTLA4; GSE; IDDM12; Celiac Disease 3; Cytotoxic T-lymphocyte protein 4

  • 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体 产品包装(模拟)
  • 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体 产品包装(模拟)
  • 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体 Briefly, biotin labelled CTLA4 Nano-antibody were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100μl were then transferred to rh CTLA4-coated microtiter wells and incubated for 1h at 37℃. Wells were washed 3 times with PBST and incubated for 0.5 h at 37℃ with SA labelled HRP. After incubation with SA labelled HRP, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450/630 nm immediately. The binding activity of rh CTLA4 and CTLA4 Nano-antibody was shown in Figure 1, and the ED50 for this effect is 0.06607 ug/ml.
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对CTLA4的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CTLA4。

用法

免疫印迹:0.2-2µg/mL;1:500-5000
免疫组织化学:5-20µg/mL;1:50-200
免疫细胞化学:5-20µg/mL;1:50-200
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPB230Hu01 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu03 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu04 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 WB; IHC; ICC; IP.
PAB230Hu01 细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 WB; IHC; ICC; IP.
FAB230Hu01 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 Flow cytometry.
FAB230Hu41 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(藻红素标记) Flow cytometry.
FAB230Hu51 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(别藻蓝蛋白标记) Flow cytometry.
FAB230Hu81 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(异硫氰酸荧光素标记) Flow cytometry.
MAB230Hu21 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB.
MAB230Hu23 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
RAB230Hu71 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体 WB; IF; ICC; IHC; IP; FCM.
MAB230Hu22 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu24 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu25 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu26 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu27 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
SEB230Hu 细胞毒性T-淋巴细胞关联抗原4(CTLA4)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB230Hu 细胞毒性T-淋巴细胞关联抗原4(CTLA4)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
PGB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)引物对 PCR

参考文献

杂志 参考文献
Int Immunopharmacol Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic … [Pubmed: 32163858]
留言咨询